🟢 Senti Biosciences is trading 13.3% up in pre-market despite no clear company-specific catalyst

Senti Biosciences is trading now at $0.34, up 13.3%, with no clear company-specific catalyst identified for September 16, 2026.

• Earlier disclosures detailed a $2.0 million convertible-note tranche and a $2.5 million equity commitment tied to merger plans; both predated the move.
• The advance broadly aligns with stronger U.S. futures, including the Nasdaq Composite’s 0.59% pre-market gain, though the larger move suggests additional speculative or liquidity-driven activity.